Bausch Health Companies Inc. (BHC): Operating Cash Flow
$1.40B
Year ended 2025-12-31
$1.80B
Trailing 12 months to 2026-06-30
+4.7%
5-year compound annual growth
-4.7%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.40B | -12.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $1.60B | +54.7% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $1.03B | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$728.00M | n/m | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $1.43B | +28.4% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $1.11B | -26.0% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $1.50B | 0.0% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $1.50B | -34.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $2.29B | +9.7% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $2.09B | -7.5% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $2.26B | -2.4% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $2.31B | +121.9% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $1.04B | +58.7% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $656.60M | n/a | 2015-02-25, From 2012-01-01 |
| No annual figure between 2010-12-31 and 2012-12-31. | |||
| 2010-12-31 | $263.19M | -27.1% | 2011-02-28, From 2010-01-01 |
| 2009-12-31 | $360.90M | +76.6% | 2011-02-28, From 2009-01-01 |
| 2008-12-31 | $204.32M | n/a | 2011-02-28, From 2008-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.40B | -12.3% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.90B | -1.7% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.63B | n/m |
| Viatris Inc (VTRS) | 2025-12-31 | $2.32B | +0.6% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $4.98B | +12.6% |
| Organon & Co. (OGN) | 2025-12-31 | $700.00M | -25.5% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.65B | +32.2% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $1.13B | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $560.00M | +3.5% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗